Literature DB >> 11513171

Gastric cardia inflammation: role of Helicobacter pylori infection and symptoms of gastroesophageal reflux disease.

S Morini1, A Zullo, C Hassan, R Lorenzetti, F Stella, M T Martini.   

Abstract

OBJECTIVE: Although high prevalences of both chronic inflammation (carditis) and intestinal metaplasia at the gastric cardia have been reported, the pathogenesis is still unclear. This study assesses the role of Helicobacter pylori (H. pylori) infection and symptoms of gastroesophageal reflux disease (GERD) in these histological alterations.
METHODS: Consecutive patients who underwent upper endoscopy were enrolled in the study, irrespective of their symptoms. Patients previously treated for H. pylori infection and those using proton pump inhibitors were excluded. Two biopsies were performed in the antrum, two in the gastric body, and two at the gastric cardia. All biopsies were used to look for H. pylori and for histological assessment.
RESULTS: A total of 133 patients were enrolled. Carditis and intestinal metaplasia at the cardia were detected in 100 (75.2%) and in 18 (13.5%) patients, respectively. The H. pylori infection rate was significantly higher in patients with carditis than in those without it (87/100 vs 7/33; p < 0.0001), and was higher in those with intestinal metaplasia at the cardia than in those without it (17/94 vs 1/39; p = 0.03). Conversely, the prevalence of GERD symptoms was not significantly different between patients with and without carditis (34/100 vs 16/33; p = NS), and between those with and without intestinal metaplasia (5/50 vs 13/83; p = NS). Interestingly, the prevalence of both H. pylori (64/94 vs 39/94; p = 0.0005) and intestinal metaplasia (18/133 vs 4/133; p = 0.0042) in the gastric cardia was significantly higher than that in gastric body.
CONCLUSION: According to our study data, the gastric cardia is frequently infected with H. pylori with consequent development of both carditis and intestinal metaplasia, whereas GERD does not seem to be involved in these histological changes.

Entities:  

Mesh:

Year:  2001        PMID: 11513171     DOI: 10.1111/j.1572-0241.2001.04038.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  11 in total

Review 1.  The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.

Authors:  P Malfertheiner; U Peitz
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

2.  High concentrations of human beta-defensin 2 in gastric juice of patients with Helicobacter pylori infection.

Authors:  Hajime Isomoto; Hiroshi Mukae; Hiroshi Ishimoto; Yoshito Nishi; Chun-Yang Wen; Akihiro Wada; Ken Ohnita; Toshiya Hirayama; Masamitsu Nakazato; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

Review 3.  Helicobacter pylori eradication in West Asia: a review.

Authors:  Hafez Fakheri; Zohreh Bari; Mohsen Aarabi; Reza Malekzadeh
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

4.  Effect of proton pump inhibitor therapy on inflammatory changes in the gastric cardia (carditis).

Authors:  Shailender Singh; Ajay Bansal; Srinivas Puli; Sachin Wani; Sharad Mathur; Amit Rastogi; Prateek Sharma
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

5.  Helicobacter pylori infection is the major risk factor for gastric inflammation in the cardia.

Authors:  Yasuo Egi; Sunjin Kim; Masanori Ito; Shinji Tanaka; Masaharu Yoshihara; Ken Haruma; Kazuaki Chayama
Journal:  Dig Dis Sci       Date:  2006-04-08       Impact factor: 3.199

6.  Helicobacter pylori therapy: Present and future.

Authors:  Vincenzo De Francesco; Enzo Ierardi; Cesare Hassan; Angelo Zullo
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-08-06

Review 7.  Oesophageal adenocarcinoma and gastric cancer: should we mind the gap?

Authors:  Yoku Hayakawa; Nilay Sethi; Antonia R Sepulveda; Adam J Bass; Timothy C Wang
Journal:  Nat Rev Cancer       Date:  2016-04-26       Impact factor: 60.716

8.  Characterization of the gastric cardia in volunteers from the general population. Type of mucosa, Helicobacter pylori infection, inflammation, mucosal proliferative activity, p53 and p21 expression, and relations to gastritis.

Authors:  Fredrik Petersson; Lennart E Franzén; Kurt Borch
Journal:  Dig Dis Sci       Date:  2009-01-23       Impact factor: 3.199

9.  Helicobacter pylori infection and gastroesophageal cancer: unveiling a Hamletic dilemma.

Authors:  Angelo Zullo; Cesare Hassan; Vincenzo De Francesco; Raffaele Manta; Adriana Romiti; Luigi Gatta
Journal:  Ann Gastroenterol       Date:  2014

Review 10.  Eradication of Helicobacter Pylori in Iran: A Review.

Authors:  Hafez Fakheri; Mehdi Saberi Firoozi; Zohreh Bari
Journal:  Middle East J Dig Dis       Date:  2017-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.